Su Fu is the Vice President of Corporate Development at the portfolio company Architect Therapeutics. She was formerly an ARCH Senior Associate focused on identifying and evaluating new life science technologies and provided operating assistance to early-stage portfolio companies. Su was an early employee at Vir Biotechnology, supporting commercial product strategy for a development pipeline from pre-clinical through pre-launch and serving as alliance lead for a portfolio of R&D collaborations.
Previously, Su was an investment professional at THL Credit, an affiliate of Thomas H. Lee Partners, focusing on healthcare and enterprise technology investments. She was also an associate with the University of Chicago Innovation Fund, where she helped researchers build scientific startups and raise seed capital. She started her career in investment banking, advising healthcare and chemical companies on financing and M&A transactions.
Ms. Fu holds an M.B.A. from The University of Chicago and a B.A. in Chemistry and Economics from Smith College, where she received the Rosenfeld Award in Organic Chemistry.